Unlocking the Future of Cell & Gene Therapies
ABOUT
We are building transformative cell & gene therapy ventures
TEAM
We are experienced cell therapy developers, innovators, and company builders
TRACK RECORD
Decades of leading the Cell & Gene frontline
OUR INVESTORS
Empowering Innovation Together
We are biotech venture builders with decades of experience in cell & gene therapies. We scout for novel ideas and breakthrough technologies, and we invest in those with disruptive, high-value potential.
With focus on product development and manufacturing innovation, we provide both capital and operational expertise to our ventures. Our goal is to accelerate their progress, ensuring they achieve preclinical proof-of-concept and clinical validation.
Our hub-and-spoke model optimizes resource allocation by centralizing capital, expertise, and talent across multiple assets. This efficient approach enables us to drive projects towards value inflection points while minimizing costs.
By mitigating clinical risks and validating our ventures' commercial potential, we create substantial value for our investors and patients alike.
BUILDING TEAMS & COMPANIES
Built and led high-performing CGTx teams and startups
C suite Pharma leadership of global 1000+ people teams
Established in international markets (US, JP, EU)
ESTABLISHING CAPABILITIES
Successful academic partnerships & strong network of innovators
Built & led CMC labs & GMP operations
Enabled partnerships with CDMOs and suppliers
Created and employed lab automation and industry 4.0 tech
DELIVERING PRODUCTS & TECH
APPROVED PRODUCTS
Kymriah®, Abecma®, Alofisel®
INDs
CARTs, CAR-NKs, iPSCs, γδT, HSCs, MSCs
MFRG. AUTOMATION
Automated cell processing, smart bioreactors, gene delivery, fill & finish
EXITS
Tidal Therapeutics, GlycoFi